These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35064617)

  • 1. Topical hydrogen peroxide solution 40% in treatment of plane wart.
    Nouh EAR; Obaid ZM; Aboelwafa HO
    J Cosmet Dermatol; 2022 Oct; 21(10):4567-4571. PubMed ID: 35064617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of different concentrations of hydrogen peroxide solution (3% and 6%) as a potential new therapeutic option of nongenital warts: A randomized controlled triple-blinded clinical trial.
    Mahran AM; Twisy HO; Elghazally SA; Badran AY
    J Cosmet Dermatol; 2020 Feb; 19(2):416-422. PubMed ID: 31175696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of nitric-zinc complex in the treatment of external genital warts and "difficult-to-treat" warts: a "proof of concept", prospective, multicentre, open study.
    Cusini M; Micali G; Lacarrubba F; Puviani M; Barcella A; Milani M
    G Ital Dermatol Venereol; 2015 Dec; 150(6):643-8. PubMed ID: 26513041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT.
    Gilson R; Nugent D; Bennett K; Doré CJ; Murray ML; Meadows J; Haddow LJ; Lacey C; Sandmann F; Jit M; Soldan K; Tetlow M; Caverly E; Nathan M; Copas AJ
    Health Technol Assess; 2020 Sep; 24(47):1-86. PubMed ID: 32975189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrogen Peroxide Topical Solution, 45% for Common Warts: Phase 2 Efficacy and Safety Trial Results.
    Smith SR; Tyring SK; Grande KK; Schlessinger J; Gold MH; Shanier SD
    J Drugs Dermatol; 2020 Oct; 19(10):969-976. PubMed ID: 33026766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and safety of topical application of diphenylcyclopropenone versus podophyllin in treatment of genital warts.
    Halim HM; Ahmed SFAE; Eyada MM
    Int J STD AIDS; 2023 Aug; 34(9):641-648. PubMed ID: 37018551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical Polyphenon E in the treatment of external genital and perianal warts: a randomized controlled trial.
    Stockfleth E; Beti H; Orasan R; Grigorian F; Mescheder A; Tawfik H; Thielert C
    Br J Dermatol; 2008 Jun; 158(6):1329-38. PubMed ID: 18363746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical imiquimod: a review of its use in genital warts.
    Perry CM; Lamb HM
    Drugs; 1999 Aug; 58(2):375-90. PubMed ID: 10473026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of a new topical nitric-zinc preparation for "difficult-to-treat" warts.
    Janniger CK; Schwartz RA
    Dermatol Ther; 2017 Mar; 30(2):. PubMed ID: 27917575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical imiquimod 5% cream as an effective treatment for external genital and perianal warts in different patient populations.
    Sauder DN; Skinner RB; Fox TL; Owens ML
    Sex Transm Dis; 2003 Feb; 30(2):124-8. PubMed ID: 12567169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topically applied treatments for external genital warts in nonimmunocompromised patients: a systematic review and network meta-analysis.
    Jung JM; Jung CJ; Lee WJ; Won CH; Lee MW; Choi JH; Chang SE
    Br J Dermatol; 2020 Jul; 183(1):24-36. PubMed ID: 31675442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy and safety of 5% imiquimod cream in external genital warts: a 6 month follow-up evaluation].
    Vexiau D; Decuypère L; Moyse D; Aractingi S
    Ann Dermatol Venereol; 2005 Nov; 132(11 Pt 1):845-51. PubMed ID: 16327713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intralesional injection of purified protein derivative versus Candida antigen in treatment of genital warts.
    Tawfik NZ; Eyada MMK; Abdel El Hamid RE; Halim HM
    Dermatol Ther; 2022 Oct; 35(10):e15762. PubMed ID: 36056784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of adjuvant imiquimod 5% cream on sustained clearance of anogenital warts following laser treatment.
    Hoyme UB; Hagedorn M; Schindler AE; Schneede P; Hopfenmüller W; Schorn K; Eul A
    Infect Dis Obstet Gynecol; 2002; 10(2):79-88. PubMed ID: 12530484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical and Systemic Retinoids for the Treatment of Genital Warts: A Systematic Review and Meta-Analysis.
    Oren-Shabtai M; Snast I; Lapidoth M; Sherman S; Noyman Y; Mimouni D; Hodak E; Levi A
    Dermatology; 2021; 237(3):389-395. PubMed ID: 33279886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single-blind study of podophyllotoxin cream 0.5% and podophyllotoxin solution 0.5% in male patients with genital warts.
    Petersen CS; Agner T; Ottevanger V; Larsen J; Ravnborg L
    Genitourin Med; 1995 Dec; 71(6):391-2. PubMed ID: 8566980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical treatment for human papillomavirus-associated genital warts in humans with the novel tellurium immunomodulator AS101: assessment of its safety and efficacy.
    Friedman M; Bayer I; Letko I; Duvdevani R; Zavaro-Levy O; Ron B; Albeck M; Sredni B
    Br J Dermatol; 2009 Feb; 160(2):403-8. PubMed ID: 18808418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imiquimod 5% cream for external genital or perianal warts in human immunodeficiency virus-positive patients treated with highly active antiretroviral therapy: an open-label, noncomparative study.
    Saiag P; Bauhofer A; Bouscarat F; Aquilina C; Ortonne JP; Dupin N; Mougin C
    Br J Dermatol; 2009 Oct; 161(4):904-9. PubMed ID: 19466962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, controlled, safety study using imiquimod for the topical treatment of anogenital warts in HIV-infected patients. Imiquimod Study Group.
    Gilson RJ; Shupack JL; Friedman-Kien AE; Conant MA; Weber JN; Nayagam AT; Swann RV; Pietig DC; Smith MH; Owens ML
    AIDS; 1999 Dec; 13(17):2397-404. PubMed ID: 10597781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical podofilox for the treatment of condylomata acuminata in women.
    Baker DA; Douglas JM; Buntin DM; Micha JP; Beutner KR; Patsner B
    Obstet Gynecol; 1990 Oct; 76(4):656-9. PubMed ID: 2216198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.